|
注册号: Registration number: |
ChiCTR2300071235 |
|
最近更新日期: Date of Last Refreshed on: |
2023-06-06 11:58:32 |
|
注册时间: Date of Registration: |
2023-05-09 00:00:00 |
|
注册号状态: |
补注册 |
|
Registration Status: |
Retrospective registration |
|
注册题目: |
Please fill in the link to the data management platform. 探究非正式痴呆症护理人员多组分干预:一项使用多阶段优化策略(MOST)的随机对照试验 |
|
Public title: |
Opening the black box of a multicomponent intervention for informal dementia caregivers: A randomized controlled trial using the multiphase optimization strategy (MOST) |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
探究非正式痴呆症护理人员多组分干预:一项使用多阶段优化策略(MOST)的随机对照试验 |
|
Scientific title: |
Opening the black box of a multicomponent intervention for informal dementia caregivers: A randomized controlled trial using the multiphase optimization strategy (MOST) |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
Dr CHOU Kee Lee |
研究负责人: |
Dr CHOU Kee Lee |
|
Applicant: |
Dr CHOU Kee Lee |
Study leader: |
Dr CHOU Kee Lee |
|
申请注册联系人电话: Applicant telephone: |
+852 18 29487473 |
研究负责人电话:
Study leader's |
+852 18 29487473 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
klchou@eduhk.hk |
研究负责人电子邮件: Study leader's E-mail: |
klchou@eduhk.hk |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
香港新界大埔露屏路10号 |
研究负责人通讯地址: |
香港新界大埔露屏路10号 |
|
Applicant address: |
10 Lo Ping Road, Tai Po, New Territories, Hong Kong |
Study leader's address: |
10 Lo Ping Road, Tai Po, New Territories, Hong Kong |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
香港教育学院 |
||
|
Applicant's institution: |
The Education University of Hong Kong |
||
|
研究负责人所在单位: |
香港教育学院 |
||
|
Affiliation of the Leader: |
The Education University of Hong Kong |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
A2020-2021-0045 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
香港教育学院伦理委员会 |
||
|
Name of the ethic committee: |
The Education University of Hong Kong, Human Research Ethics Committee |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2021-08-18 00:00:00 | ||
|
伦理委员会联系人: |
Patsy Chung |
||
|
Contact Name of the ethic committee: |
Patsy Chung |
||
|
伦理委员会联系地址: |
香港新界大埔露屏路10号 |
||
|
Contact Address of the ethic committee: |
10 Lo Ping Road, Tai Po, New Territories, Hong Kong |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+852 18 29488120 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
+852 29488120 |
|
研究实施负责(组长)单位: |
香港教育学院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Education University of Hong Kong |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
香港新界大埔露屏路10号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
10 Lo Ping Road, Tai Po, New Territories, Hong Kong |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
卫生及健康基金-卫生及健康服务(前卫生及健康基金),卫生署研究基金秘书处 |
||||||||||||||||||||||
|
Source(s) of funding: |
HMRF - Health and Health Services (former HHSRF), Research Fund Secretariat, Health Bureau |
||||||||||||||||||||||
|
研究疾病: |
痴呆 |
||||||||||||||||||||||
|
Target disease: |
Dementia |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究的目的是确定每个6个组成部分的实施保真度,并检查哪些组成部分与主要结局最密切相关,哪些部分导致相应的近端结局的改善。此外,我们希望确定各成分对其近端结局和主要结局之间的相互作用效应,以及主要结局基线评分在关联中的调节作用。 |
||||||||||||||||||||||
|
Objectives of Study: |
The purpose of this proposed study is to determine the implementation fidelity of each 6 components and to examine which components are most strongly associated with primary outcomes and which led to improvements in corresponding proximal outcomes. Also, we want to determine the interaction effect between components on their proximal outcomes and primary outcomes and the moderating effect of baseline scores of primary outcomes in the link. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
无 |
||||||||||||||||||||||
|
Exclusion criteria: |
None |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2021-04-01 00:00:00至 To 2023-11-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2021-06-01 00:00:00 至 To 2022-12-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
结束 /Completed |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
Participants will be randomly assigned to one of the 16 experimental conditions (ECs) using computer generated random numbers. All participants will receive Component 1 (Dementia and Caregiver Education) as the core intervention. Using a fractional factorial MOST design, participants will be randomly assigned to one of 16 experimental conditions that vary the delivery of treatment components. Thus, for each component, some participants will serve as the experimental (treatment) group and some will be controls. This will allow for testing the effects of each component. |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Participants will be randomly assigned to one of the 16 experimental conditions (ECs) using computer generated random numbers. All participants will receive Component 1 (Dementia and Caregiver Education) as the core intervention. Using a fractional factorial MOST design, participants will be randomly assigned to one of 16 experimental conditions that vary the delivery of treatment components. Thus, for each component, some participants will serve as the experimental (treatment) group and some will be controls. This will allow for testing the effects of each component. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
Participants will be randomly assigned to one of the 16 experimental conditions using computer generated random numbers. No interaction between participants will occur, thus the experimental conditions will be blinded to each participant. |
|
Blinding: |
Participants will be randomly assigned to one of the 16 experimental conditions using computer generated random numbers. No interaction between participants will occur, thus the experimental conditions will be blinded to each participant. |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
NA |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
NA |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
NA |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
NA |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |